These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 7585590

  • 21. Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugates.
    Schott ME, Schlom J, Siler K, Milenic DE, Eggensperger D, Colcher D, Cheng R, Kruper WJ, Fordyce W, Goeckeler W.
    Cancer; 1994 Feb 01; 73(3 Suppl):993-8. PubMed ID: 8306291
    [Abstract] [Full Text] [Related]

  • 22. Crystallographic studies and primary structure of the antitumor monoclonal CC49 Fab'.
    Abergel C, Padlan EA, Kashmiri SV, Milenic D, Calvo B, Schlom J.
    Proteins; 1993 Dec 01; 17(4):438-43. PubMed ID: 8108385
    [Abstract] [Full Text] [Related]

  • 23. Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma.
    Lubic SP, Goodwin DA, Meares CF, Song C, Osen M, Hays M.
    J Nucl Med; 2001 Apr 01; 42(4):670-8. PubMed ID: 11337558
    [Abstract] [Full Text] [Related]

  • 24. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS, Chyan MK, Hamlin DK, Vessella RL, Wedge TJ, Hawthorne MF.
    Bioconjug Chem; 2007 Apr 01; 18(4):1226-40. PubMed ID: 17583925
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In vitro system to estimate renal brush border enzyme-mediated cleavage of Peptide linkages for designing radiolabeled antibody fragments of low renal radioactivity levels.
    Fujioka Y, Satake S, Uehara T, Mukai T, Akizawa H, Ogawa K, Saji H, Endo K, Arano Y.
    Bioconjug Chem; 2005 Apr 01; 16(6):1610-6. PubMed ID: 16287261
    [Abstract] [Full Text] [Related]

  • 29. Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates.
    Quadri SM, Vriesendorp HM.
    Q J Nucl Med; 1998 Dec 01; 42(4):250-61. PubMed ID: 9973840
    [Abstract] [Full Text] [Related]

  • 30. A Gallium-67/68-Labeled Antibody Fragment for Immuno-SPECT/PET Shows Low Renal Radioactivity Without Loss of Tumor Uptake.
    Uehara T, Yokoyama M, Suzuki H, Hanaoka H, Arano Y.
    Clin Cancer Res; 2018 Jul 15; 24(14):3309-3316. PubMed ID: 29666303
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Biodistribution of monoclonal antibody and Fab fragment and antitumor effect of their conjugates on hepatoma xenografts].
    Li J, Zhen Y, Yang Z.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Oct 15; 16(5):328-33. PubMed ID: 7720121
    [Abstract] [Full Text] [Related]

  • 33. Construction and evaluation of the tumor imaging properties of 123I-labeled recombinant and enzymatically generated Fab fragments of the TAG-72 monoclonal antibody CC49.
    Tang Y, Yang S, Gariépy J, Scollard DA, Reilly RM.
    Bioconjug Chem; 2007 Oct 15; 18(3):677-84. PubMed ID: 17361988
    [Abstract] [Full Text] [Related]

  • 34. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.
    Lantry LE, Cappelletti E, Maddalena ME, Fox JS, Feng W, Chen J, Thomas R, Eaton SM, Bogdan NJ, Arunachalam T, Reubi JC, Raju N, Metcalfe EC, Lattuada L, Linder KE, Swenson RE, Tweedle MF, Nunn AD.
    J Nucl Med; 2006 Jul 15; 47(7):1144-52. PubMed ID: 16818949
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.
    Goodwin DA, Meares CF, Watanabe N, McTigue M, Chaovapong W, Ransone CM, Renn O, Greiner DP, Kukis DL, Kronenberger SI.
    Cancer Res; 1994 Nov 15; 54(22):5937-46. PubMed ID: 7954426
    [Abstract] [Full Text] [Related]

  • 36. Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.
    Tolmachev V, Orlova A, Pehrson R, Galli J, Baastrup B, Andersson K, Sandström M, Rosik D, Carlsson J, Lundqvist H, Wennborg A, Nilsson FY.
    Cancer Res; 2007 Mar 15; 67(6):2773-82. PubMed ID: 17363599
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneum.
    Rauch C, Seidl C, Schlapschy M, Skerra A, Morgenstern A, Bruchertseifer F, Senekowitsch-Schmidtke R.
    Nucl Med Biol; 2012 Jul 15; 39(5):617-27. PubMed ID: 22381781
    [Abstract] [Full Text] [Related]

  • 39. Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications.
    Kim MK, Jeong HJ, Kao CH, Yao Z, Paik DS, Pie JE, Kobayashi H, Waldmann TA, Carrasquillo JA, Paik CH.
    Nucl Med Biol; 2002 Feb 15; 29(2):139-46. PubMed ID: 11823118
    [Abstract] [Full Text] [Related]

  • 40. (67/68)Ga-labeling agent that liberates (67/68)Ga-NOTA-methionine by lysosomal proteolysis of parental low molecular weight polypeptides to reduce renal radioactivity levels.
    Uehara T, Rokugawa T, Kinoshita M, Nemoto S, Fransisco Lazaro GG, Hanaoka H, Arano Y.
    Bioconjug Chem; 2014 Nov 19; 25(11):2038-45. PubMed ID: 25303645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.